Toxic relationships don’t just happen in romance, families, or friendships—they can happen in your body too. Type 2 diabetes (T2D) and obesity form one such harmful partnership, creating a cycle of worsened blood sugar and weight gain.
Fortunately, Rybelsus, the revolutionary oral semaglutide by Novo Nordisk, empowers patients to fight T2D and obesity—a pairing that coexists in over 90% of cases—this game-changing treatment delivers effective blood sugar control and sustainable weight loss.